Welcome!
If You are a pet parent looking for common sense advice, read on …
Dr. Elizabeth Carney wants to empower YOU to take an active role in your pet’s health and well-being. After all no one knows your pet better than you!
2nd Quarter 2016 ADE Reports: Bravecto, Nexgard, and Simparica
I have received Adverse Drug Event Reports from FDA for Bravecto, Nexgard, and Simparica, encompassing dates 4/1/2016 - 7/15/2016. Below is a reminder about how to read and use these reports; this is text taken verbatim from the beginning of the report. For any given ADE report, there is no certainty that the reported drug caused the adverse event. The adverse event may have been related to an underlying disease, using other drugs at the same time, or other non-drug related causes. The clinical detail listing does not include information about underlying diseases, other drugs used at the same time, other non-drug related causes, or the final outcome of the reaction. The accuracy of information regarding the ADE is dependent on the … [Read More...]
First Quarter 2016 Nexgard and Bravecto FDA ADE Reports
I have received Adverse Drug Event Reports from FDA for Bravecto and Nexgard, encompassing dates January 7, 2016 through March 31, 2016. Below is a reminder about how to read and use these reports; this is text taken verbatim from the beginning of the report. For any given ADE report, there is no certainty that the reported drug caused the adverse event. The adverse event may have been related to an underlying disease, using other drugs at the same time, or other non-drug related causes. The clinical detail listing does not include information about underlying diseases, other drugs used at the same time, other non-drug related causes, or the final outcome of the reaction. The accuracy of information regarding the ADE is dependent on … [Read More...]
Check out Rover.com!
Have you heard of Rover.com? It's a site that connects pet parents with dog sitters, dog walkers, and doggie daycare across the country. Recently, one of the staff writers for the site's blog (The Daily Treat), contacted me to see if I'd participate in an article she was working on. The article focuses on what inspired a few of us veterinarians to enter our profession. I'd love it if you'd take a moment to read it! Click here to check it out! … [Read More...]
Zoetis (Pfizer) joins in with Simparica, competition for Bravecto and Nexgard
Today I received an email from Zoetis (formerly Pfizer), promoting the company's newly approved flea/tick preventive called Simparica. This medication contains the chemical sarolaner, which is closely related to the drugs afoxolaner (Nexgard) and fluralaner (Bravecto). I've spent countless hours on my blog responding to comments about Nexgard and Bravecto after I posted about them in November 2014. It is no surprise to me that Zoetis has jumped on this bandwagon. Here's the lowdown on Simparica, based on the company-provided product insert. Which Dogs Can Take It? Dogs must be at least 6 months of age, weighing at least 2.8 pounds. Zoetis has NOT evaluated the use of Simparica in breeding, pregnant, or lactating dogs. How Do I Give … [Read More...]
Second Half of 2015 Nexgard and Bravecto ADE Reports
I am so pleased to say that my 01/06/16 FOIA request for Bravecto/Nexgard Adverse Drug Event reports has been fulfilled! This is record timing compared to the last request, which took 5 months. As anticipated, there were a large number of reports during the time period encompassing 06/18/15 - 01/06/16, as follows: Afoxolaner (Nexgard): 2,048 reports Fluralaner (Bravecto): 2,852 reports This is compared to the previous report I received in November 2015, encompassing 1/1/13 - 06/17/15: Afoxolaner (Nexgard): 5,087 Fluralaner (Bravecto): 2,467 I'd like to gently remind you of the following points as you read these reports. This information is taken from the first two pages, and it's important to view all of this data with … [Read More...]
Search
Dr. Carney’s In Home Practice
